FOXC1 contributes to microvascular invasion in primary hepatocellular carcinoma via regulating epithelial-mesenchymal transition

International Journal of Biological Sciences

Volumn 8, Issue 8, 2012, Pages 1130-1141

  Xu, Zhi Yuan ^a,b   Ding, Song Ming ^a,b   Zhou, Lin ^a,b   Xie, Hai Yang ^a,b   Chen, Kang Jie ^a,b   Zhang, Wu ^a,b   Xing, Chun Yan ^a,b   Guo, Hai Jun ^a,b   Zheng, Shu Sen ^a,b  

^a BEIJING HOSPITAL   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Epithelial Mesenchymal Transi tion; FOXC1; Hepatocellular carcinoma; Microvascular invasion

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; FOXC1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; CLONOGENIC ASSAY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GROWTH, DEVELOPMENT AND AGING; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MICROVASCULATURE; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; COLONY-FORMING UNITS ASSAY; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LIVER NEOPLASMS; MALE; MICROVESSELS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; TRANSCRIPTION FACTORS;

EID: 84867500111     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.4769     Document Type: Article

References (32)

1. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology. 2006; 131: 1743-1751.
2. Poon RT, Fan ST, Tsang FH, et al. Locoregional therapies for hepatocel-lular carcinoma: a critical review from the surgeon's perspective. Ann Surg. 2002; 235: 466-486.
3. Hu J, Wang Z, Fan J, et al. Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence af-ter liver transplantation. PLoS One. 2011; 6: e26003.
4. Roayaie S, Frischer JS, Emre SH, et al. Long-term results with multi-modal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg. 2002; 235: 533-539.
5. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl. 2002; 8: 765-774.
6. Kurrey NK, Jalgaonkar SP, Joglekar AV, et al. Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells. 2009; 27: 2059-2068.
7. Taube JH, Herschkowitz JI, Komurov K, et al. Core epitheli-al-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A. 2010; 107: 15449-15454.
8. Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the cross-roads of development and tumor metastasis. Dev Cell. 2008; 14: 818-829.
9. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transi-tion. J Clin Invest. 2009; 119: 1420-1428.
10. Bonnomet A, Brysse A, Tachsidis A, et al. Epithelial-to-mesenchymal transitions and circulating tumor cells. J Mammary Gland Biol Neo-plasia. 2010; 15: 261-273.
11. Klymkowsky MW, Savagner P. Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am J Pathol. 2009; 174: 1588-1593.
12. Hartwell KA, Muir B, Reinhardt F, et al. The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proc Natl Acad Sci U S A. 2006; 103: 18969-18974.
13. Batlle E, Sancho E, Franci C, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000; 2: 84-89.
14. Hajra KM, Chen DY, Fearon ER. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 2002; 62: 1613-1618.
15. Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of mor-phogenesis, plays an essential role in tumor metastasis. Cell. 2004; 117: 927-939.
16. Bloushtain-Qimron N, Yao J, Snyder EL, et al. Cell type-specific DNA methylation patterns in the human breast. Proc Natl Acad Sci U S A. 2008; 105: 14076-14081.
17. Ray PS, Wang J, Qu Y, et al. FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer. Cancer Res. 2010; 70: 3870-3876.
18. Mani SA, Yang J, Brooks M, et al. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci U S A. 2007; 104: 10069-10074.
19. Eger A, Aigner K, Sonderegger S, et al. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast can-cer cells. Oncogene. 2005; 24: 2375-2385.
20. Comijn J, Berx G, Vermassen P, et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell. 2001; 7: 1267-1278.
21. Li H, Wang H, Wang F, et al. Snail involves in the transforming growth factor beta1-mediated epithelial-mesenchymal transition of retinal pig-ment epithelial cells. PLoS One. 2011; 6: e23322.
22. Lu W, Dong J, Huang Z, et al. Comparison of four current staging sys-tems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP, TNM and CUPI. J Gastroenterol Hepatol. 2008; 23: 1874-1878.
23. Cheng J, Xie HY, Xu X, et al. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma. Cancer Lett. 2011; 310: 35-45.
24. Hannenhalli S, Kaestner KH. The evolution of Fox genes and their role in development and disease. Nat Rev Genet. 2009; 10: 233-240.
25. Zarbalis K, Siegenthaler JA, Choe Y, et al. Cortical dysplasia and skull defects in mice with a Foxc1 allele reveal the role of meningeal differen-tiation in regulating cortical development. Proc Natl Acad Sci U S A. 2007; 104: 14002-14007.
26. Aldinger KA, Lehmann OJ, Hudgins L, et al. FOXC1 is required for normal cerebellar development and is a major contributor to chromo-some 6p25.3 Dandy-Walker malformation. Nat Genet. 2009; 41: 1037-1042.
27. Wang J, Ray PS, Sim MS, et al. FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-kappaB signaling. Onco-gene. 2012.
28. Sizemore ST, Keri RA. The Forkhead Box Transcription Factor FOXC1 Promotes Breast Cancer Invasion by Inducing Matrix Met alloprotease 7 (MMP7) Expression. J Biol Chem. 2012; 287: 24631-24640.
29. Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 2009; 28: 15-33.
30. Sommer P, Napier HR, Hogan BL, et al. Identification of Tgf beta1i4 as a downstream target of Foxc1. Dev Growth Differ. 2006; 48: 297-308.
31. Hayashi H, Kume T. Forkhead transcription factors regulate expression of the chemokine receptor CXCR4 in endothelial cells and CXCL12-induced cell migration. Biochem Biophys Res Commun. 2008; 367: 584-589.
32. Qi J, Chen N, Wang J, et al. Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the be-ta-catenin signaling pathway. Mol Biol Cell. 2005; 16: 4386-4397.